• AVORTEMENT PAR MÉDICAMENTS
  • SOGC.ORG
  • Accueil
  • Prescrire
  • Dispenser
  • Rôles de soutien
  • FAQ
  • À propos de nous
  • EN
  • Sortir
  • Accueil
  • Prescrire
  • Dispenser
  • Rôles de soutien
  • FAQ
  • À propos de nous
  • EN
  • Sortir
Read More
By: Aashay MehtaPosted on March 19, 2025March 28, 2025

Toolkits for Addressing Abortion Concerns

Debunking medication abortion myths, 2023Canadian Pharmacists Association & The CART Access ProjectLink: [cpha-debunking-myth](CPHA3) The Abortion options: A value clarification guide for health care professionals, 2005National Abortion […]

Read More
By: Aashay MehtaPosted on March 19, 2025March 28, 2025

Toolkits for Supporting Underserved Communities

A handbook for healthcare providers working with clients from diverse communities, 2019Action Canada for Sexual Health & RightsLink: [action-canada-handbook](C104-1) The Indigenous ally toolkit, 2018Montreal Urban Aboriginal […]

Read More
By: Aashay MehtaPosted on March 16, 2025March 20, 2025

Side-effect Management

Read More
By: Aashay MehtaPosted on March 16, 2025March 20, 2025

Missed Doses

If MIFE is forgotten, the patient should take it as soon as they remember. If it has been more than 48 hours since the patient […]

Read More
By: Aashay MehtaPosted on March 16, 2025March 20, 2025

Administration Instruction

Read More
By: Aashay MehtaPosted on March 16, 2025March 20, 2025

Indication & Contraindications

Indication MIFE / MISO is indicated by [Health Canada](C17-2) for pregnancy termination up to 63 days as counted from the first day of the last […]

Posts navigation

Next

Archives

  • March 2025

Categories

  • About
  • Dispenser
  • Dispensing
  • FAQ
  • Prescribing
  • Prescrire
  • Soutien
  • Supporting
Share-alt Print Facebook-f Twitter Youtube

NOUS JOINDRE

  • 2781 chemin Lancaster, bureau 200Ottawa, Ontario, K1B 1A7
    (800) 561-2416
    (613) 730-4192
  • Info@sogc.com

© 2024 tous droits réservés | Politique de confidentialité | Conditions d’utilisation | À propos |